4//SEC Filing
Ogren D John 4
Accession 0001140361-13-000200
CIK 0001000229other
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 4:13 PM ET
Size
8.8 KB
Accession
0001140361-13-000200
Insider Transaction Report
Form 4
Ogren D John
Director
Transactions
- Exercise/Conversion
Restricted Performance Shares
2012-12-31−1,530→ 0 totalExercise: $0.00→ Common Shares (1,530 underlying) - Tax Payment
Common Shares
2012-12-31$109.31/sh−13$1,421→ 37,825 total - Exercise/Conversion
Common Shares
2012-12-31+1,530→ 37,838 total
Footnotes (1)
- [F1]The shares vesting were awarded as restricted performance shares in April 2010. As reported in the Form 4 filing on April 5, 2010 at the time the award was made, "The Restricted Performance Shares vest based on the Company's return on invested capital for the period that began on January 1, 2010 and ends on December 31, 2012 (the "performance period") as follows. If the Company's return on invested capital at the end of the performance period is in the top decile of the return on invested capital of the Company's peers as published by Bloomberg, then the Restricted Performance Shares will fully vest. If this criteria is not met, then no shares shall vest and the award will be forfeited." The performance criteria and all requirements for vesting have been met and thus the shares fully vested on December 31, 2012, at the conclusion of the performance period.
Documents
Issuer
CORE LABORATORIES N V
CIK 0001000229
Entity typeother
Related Parties
1- filerCIK 0001309016
Filing Metadata
- Form type
- 4
- Filed
- Jan 1, 7:00 PM ET
- Accepted
- Jan 2, 4:13 PM ET
- Size
- 8.8 KB